Relyvrio, were on track for 10,000 patient level in the USA. They reached approx 1/3 of that.
The annual price was approx us$160,000 per patient.
Thats us$1.6b revenue annually.
Pharma industry colloquial description for a blockbuster, is greater than us$1b revenue. It was a throwaway line from Michael, trying to describe how big we could be without giving specifics, imho.
NZT gone but hasn't forgotten, page-43
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.020(9.09%) |
Mkt cap ! $95.01M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 24.5¢ | 22.0¢ | $254.9K | 1.085M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10127 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 200825 | 6 |
View Market Depth
| Last trade - 16.10pm 11/06/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
0.020 ( 9.30 %) |
||||
| Open | High | Low | Volume | ||
| 21.5¢ | 24.5¢ | 21.5¢ | 724342 | ||
| Last updated 15.59pm 11/06/2024 ? | |||||
| PAA (ASX) Chart |